What’s Next? Five Things To Look Out For In February
Accord Plans To Roll Out Generic Revlimid In More European Markets
Executive Summary
In February, key launches from Accord and Eagle are set to go ahead, while Viatris will host its delayed investor day and industry will meet in-person in Florida for the US Association for Accessible Medicines’ Access! event.